• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Clinical phenotypes, molecular analysis, and outcomes of patients with Rosai-Dorfman disease.

作者信息

Chang Long, Qiao Bing, Cai Hao, Lin He, Duan Ming-Hui, Li Jian, Zhou Dao-Bin, Goyal Gaurav, Sun Chun-Yan, Cao Xin-Xin

机构信息

Department of Hematology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.

State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Beijing, China.

出版信息

Leukemia. 2023 Nov;37(11):2297-2300. doi: 10.1038/s41375-023-02032-6. Epub 2023 Sep 20.

DOI:10.1038/s41375-023-02032-6
PMID:37731024
Abstract
摘要

相似文献

1
Clinical phenotypes, molecular analysis, and outcomes of patients with Rosai-Dorfman disease.罗萨伊-多夫曼病患者的临床表型、分子分析及预后
Leukemia. 2023 Nov;37(11):2297-2300. doi: 10.1038/s41375-023-02032-6. Epub 2023 Sep 20.
2
Sinus histiocytosis with massive lymphadenopathy (Rosai-Dorfman disease).伴巨大淋巴结病的窦组织细胞增生症（罗萨伊-多夫曼病）
Int J Pediatr Otorhinolaryngol. 1998 Jul 10;44(2):173-6. doi: 10.1016/s0165-5876(98)00052-4.
3
Extranodal manifestation of Rosai-Dorfman disease without involvement of lymph nodes.罗萨伊-多夫曼病的结外表现，无淋巴结受累。
J Craniofac Surg. 2010 Nov;21(6):1733-6. doi: 10.1097/SCS.0b013e3181f403ad.
4
Extranodal Rosai-Dorfman disease presenting as an isolated epibulbar mass.表现为孤立性眼球表面肿物的结外Rosai-Dorfman病
Indian J Ophthalmol. 2008 Nov-Dec;56(6):502-4. doi: 10.4103/0301-4738.43372.
5
Rosai-Dorfman disease presenting as bilateral lacrimal gland enlargement.以双侧泪腺肿大为表现的罗萨伊-多夫曼病
Am J Ophthalmol. 2001 May;131(5):677-8. doi: 10.1016/s0002-9394(00)00864-3.
6
[Cutaneous sinus histiocytosis (Rosai-Dorfman disease)].[皮肤窦组织细胞增生症（罗萨伊-多夫曼病）]
Hautarzt. 1998 May;49(5):392-6. doi: 10.1007/s001050050761.
7
Isolated intracranial Rosai-Dorfman disease (sinus histiocytosis with massive lymphadenopathy).孤立性颅内罗萨伊-多夫曼病（伴巨大淋巴结病的窦性组织细胞增多症）。
AJNR Am J Neuroradiol. 2003 Mar;24(3):515-8.
8
A Case Indistinguishable Between Indeterminate Cell Histiocytosis and Cutaneous Rosai-Dorfman Disease.一例无法区分的不确定细胞组织细胞增多症与皮肤Rosai-Dorfman病
J Cutan Med Surg. 2017 Jan/Feb;21(1):68-71. doi: 10.1177/1203475416664038. Epub 2016 Aug 20.
9
[Rosai-Dorfman disease: Diagnosis and therapeutic challenges].[罗萨伊-多夫曼病：诊断与治疗挑战]
Rev Med Interne. 2018 Aug;39(8):635-640. doi: 10.1016/j.revmed.2018.02.011. Epub 2018 Mar 1.
10
Sinus histiocytosis and massive lymphadenopathy (Rosai-Dorfman disease) mimicking cervical lymphadenitis.模仿颈部淋巴结炎的窦性组织细胞增生症和巨大淋巴结病（罗萨伊-多夫曼病）
J Pediatr. 2014 Apr;164(4):943-943.e1. doi: 10.1016/j.jpeds.2013.12.001. Epub 2014 Jan 10.

引用本文的文献

1
Retrospective nationwide survey of pediatric RDD in Japan: a high prevalence of mutations in the kinase pathway genes.日本儿童Rosai-Dorfman病的全国性回顾性调查：激酶途径基因突变的高发生率
Int J Hematol. 2025 Mar 10. doi: 10.1007/s12185-025-03962-w.
2
Unraveling Histiocytic Disorders: Two Cases From Resource-Limited Settings.解析组织细胞疾病：来自资源有限地区的两个病例
Cureus. 2024 Dec 30;16(12):e76622. doi: 10.7759/cureus.76622. eCollection 2024 Dec.
3
Clinical Spectrum and Outcome of Kidney Involvement in Non-Langerhans Histiocytosis.

本文引用的文献

1
Outcomes After Treatment With Cobimetinib in Patients With Rosai-Dorfman Disease Based on KRAS and MEK Alteration Status.基于 KRAS 和 MEK 改变状态的考比替尼治疗罗道尔夫病患者的结局。
JAMA Oncol. 2022 Dec 1;8(12):1816-1820. doi: 10.1001/jamaoncol.2022.4432.
2
International expert consensus recommendations for the diagnosis and treatment of Langerhans cell histiocytosis in adults.国际专家共识建议：成人朗格汉斯细胞组织细胞增生症的诊断与治疗。
Blood. 2022 Apr 28;139(17):2601-2621. doi: 10.1182/blood.2021014343.
3
Diverse kinase alterations and myeloid-associated mutations in adult histiocytosis.
非朗格汉斯组织细胞增多症肾脏受累的临床谱及转归
Kidney Int Rep. 2024 Oct 10;10(1):209-216. doi: 10.1016/j.ekir.2024.09.027. eCollection 2025 Jan.
4
Lenalidomide and dexamethasone for Rosai-Dorfman disease: a single arm, single center, prospective phase 2 study.来那度胺和地塞米松治疗罗萨伊-多夫曼病：一项单臂、单中心、前瞻性2期研究。
EClinicalMedicine. 2024 Jun 21;73:102685. doi: 10.1016/j.eclinm.2024.102685. eCollection 2024 Jul.
5
Rosai-Dorfman disease of the kidney: a case description and literature analysis.肾脏的罗萨伊-多夫曼病：病例描述与文献分析
Quant Imaging Med Surg. 2024 Jan 3;14(1):1219-1224. doi: 10.21037/qims-23-773. Epub 2023 Nov 6.
成人组织细胞增多症中的多种激酶改变和髓系相关突变
Leukemia. 2022 Feb;36(2):573-576. doi: 10.1038/s41375-021-01439-3. Epub 2021 Oct 5.
4
Clinicopathological features, treatment approaches, and outcomes in Rosai-Dorfman disease.罗萨达-多夫曼病的临床病理特征、治疗方法和结局。
Haematologica. 2020 Jan 31;105(2):348-357. doi: 10.3324/haematol.2019.219626. Print 2020.
5
Consensus recommendations for the diagnosis and clinical management of Rosai-Dorfman-Destombes disease.罗萨-多夫曼-德斯东贝病的诊断和临床管理共识建议。
Blood. 2018 Jun 28;131(26):2877-2890. doi: 10.1182/blood-2018-03-839753. Epub 2018 May 2.
6
Rosai-Dorfman disease successfully treated with thalidomide.沙利度胺成功治疗罗萨伊-多夫曼病。
JAAD Case Rep. 2016 Sep 28;2(5):369-372. doi: 10.1016/j.jdcr.2016.08.006. eCollection 2016 Sep.
7
Revised classification of histiocytoses and neoplasms of the macrophage-dendritic cell lineages.巨噬细胞-树突状细胞谱系组织细胞增多症和肿瘤的修订分类
Blood. 2016 Jun 2;127(22):2672-81. doi: 10.1182/blood-2016-01-690636. Epub 2016 Mar 10.
8
Diverse and Targetable Kinase Alterations Drive Histiocytic Neoplasms.多样且可靶向的激酶改变驱动组织细胞肿瘤。
Cancer Discov. 2016 Feb;6(2):154-65. doi: 10.1158/2159-8290.CD-15-0913. Epub 2015 Nov 13.
9
Lenalidomide in the treatment of Rosai Dorfman disease--a first in use report.来那度胺治疗罗萨伊-多夫曼病——首次使用报告
Am J Hematol. 2016 Feb;91(2):E1. doi: 10.1002/ajh.24225.
10
Symptomatic extranodal Rosai-Dorfman disease treated with steroids, radiation, and surgery.采用类固醇、放疗和手术治疗的有症状的结外Rosai-Dorfman病。
J Clin Oncol. 2011 Nov 1;29(31):e772-5. doi: 10.1200/JCO.2011.36.9967. Epub 2011 Sep 19.